High-Resolution Computed Tomography Findings for Patients With Drug-Induced Pulmonary Toxicity, With Special Reference to Hypersensitivity Pneumonitis-Like Patterns in Gemcitabine-Induced Cases

Author:

Tamura Masaki1,Saraya Takeshi1,Fujiwara Masachika2,Hiraoka Sayuki3,Yokoyama Takuma1,Yano Kinuko4,Ishii Haruyuki1,Furuse Junji5,Goya Tomoyuki6,Takizawa Hajime1,Goto Hajime1

Affiliation:

1. a Departments of Respiratory Medicine, Kyorin University School of Medicine, Tokyo, Japan

2. b Departments of Pathology, Kyorin University School of Medicine, Tokyo, Japan

3. c Departments of Radiology, Kyorin University School of Medicine, Tokyo, Japan

4. d Departments of Pharmaceuticals, Kyorin University School of Medicine, Tokyo, Japan

5. e Departments of Oncology, Kyorin University School of Medicine, Tokyo, Japan

6. f Departments of General Surgery, Kyorin University School of Medicine, Tokyo, Japan

Abstract

Abstract Background. Gemcitabine (GEM) is widely used as a chemotherapeutic agent. However, pulmonary toxicity has been rarely observed with GEM use. This article aims to determine the incidence and causes of drug-induced pulmonary toxicity, and to classify the high-resolution computed tomography (HRCT) findings for antitumor therapy-associated pulmonary toxicity based on characteristic patterns and pathological considerations, with a special focus on GEM-associated pulmonary toxicity (GAPT). Methods. Medical records of all patients with drug-induced pulmonary toxicity seen at Kyorin University hospital between April 2006 and December 2011 were retrospectively reviewed. The study examined correlations between HRCT and the assessed pathological or clinical findings, with a specific focus on antitumor drugs. Results. We identified 66 patients with drug-induced pulmonary toxicity. Among the antitumor drugs, GEM was the primary offending agent (n = 8) for pulmonary toxicity followed by docetaxel and gefitinib. HRCT patterns for the eight GAPT patients included the non-specific interstitial pneumonia (NSIP; n = 5) and the hypersensitivity pneumonitis (HP)-like pattern (n = 3). In contrast, four patients in the study were found to have the HP-like pattern, with three cases associated with GEM and one case associated with imatinib mesylate. The transbronchial lung biopsy or video-assisted thoracic surgery specimens for these patients showed granuloma or organizing tissue with a random distribution that was independent of the respiratory bronchiole. These results appeared to correspond to the HRCT-determined centrilobular nodules. Conclusion. GEM was the leading cause of drug-induced pulmonary toxicity in the patients examined in this study. This toxicity appears as NSIP or an HP-like pattern during HRCT examinations. This HP-like pattern may be useful for diagnosing GEM-induced pulmonary toxicity, as well as demonstrating granuloma or organizing tissue during lung pathology examinations.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference12 articles.

1. Pulmonary toxicity associated with gemcitabine;Saif;JOP,2010

2. Fleischner Society: Glossary of terms for thoracic imaging;Hansell;Radiology,2008

3. Non-specific interstitial pneumonia: Findings on sequential CT scans of nine patients;Akira;Thorax,2000

4. [A case of imatinib mesylate-induced pneumonitis based on the detection of epithelioid granulomas by video-assisted thoracoscopic surgery biopsy in a patient with chronic myeloid leukemia];Koide;Nihon Kokyuki Gakkai Zasshi,2011

5. [Acute pulmonary toxicity due to gemcitabine: A role for asbestos exposure?];Barlesi;Rev Mal Respir,2003

Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3